ADTN

$5.0619.43%-1.22

Nachbörslich: 5.14+0.08 +1.58%

Adtran Holdings Inc (ADTN)

Date: O: H: L: C: Vol:

Schlusskurs vom Vortag:

$6.28

Offen:

$6.18

24-Stunden-Volumen:

4,399,216

Relatives Volumen:

2.58

Marktkapitalisierung:

$412.30M

Einnahmen:

$1.12B

Nettoeinkommen (Verlust:

-$24.05M

KGV:

EPS:

-$0.3925

Netto-Cashflow:

$32.75M

1W Leistung:

-26.45%

1M Leistung:

-28.13%

6M Leistung:

-72.57%

1Y Leistung:

-51.49%

1-Tages-Spanne:

$5.03$6.20

1-Wochen-Bereich:

$5.03$6.98

52-Wochen-Spanne:

$5.03$19.98

Adtran Holdings Inc Aktie (ADTN) Unternehmensprofil

Firmenname

Adtran Holdings Inc

Sektor

Technology

Branche

Communication Equipment

Telefon

256-963-8220

Adresse

901 EXPLORER BLVD, HUNTSVILLE, AL, USA

Mitarbeiter

3,338

@adtran

Nächster Verdiensttermin

null

Neueste SEC-Einreichungen

SEC

ADTN-Diskussionen auf X

Marktkapitalisierung

Umsatz

Nettogewinn

Free Cashflow

ENV

Adtran Holdings Inc Aktie (ADTN) Hochstufungen & Herabstufungen

Datum	Aktion	Analytiker	Ratingänderung
2026-11-03	Herabstufung	Rosenblatt	Buy → Neutral
2026-04-14	Eingeleitet	Evercore ISI	Outperform
2025-09-18	Eingeleitet	B. Riley Securities	Buy
2025-07-08	Eingeleitet	Wolfe Research	Peer Perform
2025-01-08	Eingeleitet	Craig Hallum	Buy
2024-11-08	Hochstufung	Rosenblatt	Neutral → Buy
2024-05-08	Hochstufung	Northland Capital	Market Perform → Outperform
2023-11-20	Herabstufung	Argus	Buy → Hold
2023-11-07	Herabstufung	Rosenblatt	Buy → Neutral
2023-04-12	Herabstufung	Northland Capital	Outperform → Market Perform
2022-09-26	Hochstufung	Loop Capital	Hold → Buy
2022-07-14	Eingeleitet	Needham	Buy
2022-04-12	Eingeleitet	Rosenblatt	Buy
2022-02-23	Eingeleitet	Loop Capital	Hold
2021-08-06	Hochstufung	Cowen	Market Perform → Outperform
2021-05-14	Hochstufung	Argus	Hold → Buy
2021-02-05	Hochstufung	Needham	Hold → Buy
2020-11-04	Hochstufung	Jefferies	Hold → Buy
2020-04-17	Hochstufung	Goldman	Neutral → Buy
2020-03-27	Hochstufung	MKM Partners	Neutral → Buy
2020-03-26	Hochstufung	Northland Capital	Market Perform → Outperform
2019-10-10	Herabstufung	MKM Partners	Buy → Neutral
2019-01-29	Herabstufung	Needham	Buy → Hold
2018-10-18	Bestätigt	Needham	Buy
2018-09-13	Hochstufung	BofA/Merrill	Underperform → Neutral
2018-07-18	Herabstufung	Northland Capital	Outperform → Market Perform
2018-04-19	Herabstufung	Argus	Buy → Hold
2018-04-19	Bestätigt	Needham	Buy
2018-01-16	Hochstufung	Goldman	Sell → Neutral
2018-01-12	Bestätigt	Needham	Buy
2017-12-29	Bestätigt	MKM Partners	Buy
2017-08-10	Bestätigt	Needham	Buy
2017-07-20	Bestätigt	Needham	Buy
2017-04-20	Hochstufung	Argus	Hold → Buy
2017-04-20	Bestätigt	Needham	Buy
2016-10-31	Hochstufung	Northland Capital	Market Perform → Outperform
2016-04-19	Herabstufung	Goldman	Neutral → Sell

Finanzdaten der Adtran Holdings Inc-Aktie (ADTN)

Zeitraum	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Enddatum des Zeitraums	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Revenue USD (M)	1,083.81	922.72	1,149.10	1,025.54	563.00
Cost of revenue USD (M)	668.85	598.56	816.04	698.28	344.63
Gross profit USD (M)	414.96	324.16	333.06	327.25	218.38
Research and development USD (M)	204.28	221.46	258.31	173.76	108.66
Operating expenses USD (M)	-	-	554.33	400.08	233.08
Operating income USD (M)	-15.60	-427.57	-221.27	-72.83	-14.70
Income before tax USD (M)	-31.25	-442.73	-231.21	-70.96	-6.31
Income tax expense USD (M)	4.99	7.34	28.13	-62.08	2.33
Net income USD (M)	-36.24	-450.07	-259.34	-8.89	-8.64
Basic EPS USD/shares	-0.52	-5.79	-3.41	-0.03	-0.18
Diluted EPS USD/shares	-0.52	-5.79	-3.41	-0.03	-0.18
Basic weighted shares shares (M)	79.74	78.93	78.42	62.35	48.58
Diluted weighted shares shares (M)	79.74	78.93	78.42	62.35	48.58
Selling, general and administrative USD (M)	226.28	232.92	258.15	208.89	124.41

Adtran Holdings Inc-Aktie (ADTN) Insiderhandel

Santo Timothy PAug 06 '26
SVP of Finance; CFO
Transaktion
Buy
Kosten
$7.60
#Aktien
6,579
Wert ($)
50,000
#Aktien Gesamt
59,924
Wilson James Denson JrMay 20 '26
Chief Revenue Officer
Transaktion
Sale
Kosten
$14.72
#Aktien
9,332
Wert ($)
137,367
#Aktien Gesamt
143,277
JAMES D WILSON JRMay 20 '26
Officer
Transaktion
Proposed Sale
Kosten
$14.72
#Aktien
9,332
Wert ($)
137,409
#Aktien Gesamt
0
Glingener ChristophMay 08 '26
Chief Technology Officer
Transaktion
Sale
Kosten
$15.00
#Aktien
22,277
Wert ($)
334,155
#Aktien Gesamt
46,645
Glingener ChristophMay 08 '26
Chief Technology Officer
Transaktion
Option Exercise
Kosten
$12.17
#Aktien
22,277
Wert ($)
271,111
#Aktien Gesamt
68,922
Glingener ChristophMay 07 '26
Chief Technology Officer
Transaktion
Sale
Kosten
$14.95
#Aktien
126,115
Wert ($)
1,885,689
#Aktien Gesamt
46,645
Glingener ChristophMay 07 '26
Chief Technology Officer
Transaktion
Option Exercise
Kosten
$10.48
#Aktien
126,115
Wert ($)
1,322,124
#Aktien Gesamt
131,540
CHRISTOPH GLINGENERMay 07 '26
Officer
Transaktion
Proposed Sale
Kosten
$15.71
#Aktien
148,392
Wert ($)
2,331,238
#Aktien Gesamt
0
Jacqueline Hourigan RiceMar 04 '26
Director
Transaktion
Sale
Kosten
$10.29
#Aktien
14,406
Wert ($)
148,238
#Aktien Gesamt
13,809
JACQUELINE H RICEMar 04 '26
Director
Transaktion
Proposed Sale
Kosten
$10.29
#Aktien
14,406
Wert ($)
148,267
#Aktien Gesamt
0

Insiderhandel	Beziehung	Datum	Transaktion	Kosten	#Aktien	Wert ($)	#Aktien Gesamt
Santo Timothy P	SVP of Finance; CFO	Aug 06 '26	Buy	$7.60	6,579	50,000	59,924
Wilson James Denson Jr	Chief Revenue Officer	May 20 '26	Sale	$14.72	9,332	137,367	143,277
JAMES D WILSON JR	Officer	May 20 '26	Proposed Sale	$14.72	9,332	137,409	0
Glingener Christoph	Chief Technology Officer	May 08 '26	Sale	$15.00	22,277	334,155	46,645
Glingener Christoph	Chief Technology Officer	May 08 '26	Option Exercise	$12.17	22,277	271,111	68,922
Glingener Christoph	Chief Technology Officer	May 07 '26	Sale	$14.95	126,115	1,885,689	46,645
Glingener Christoph	Chief Technology Officer	May 07 '26	Option Exercise	$10.48	126,115	1,322,124	131,540
CHRISTOPH GLINGENER	Officer	May 07 '26	Proposed Sale	$15.71	148,392	2,331,238	0
Jacqueline Hourigan Rice	Director	Mar 04 '26	Sale	$10.29	14,406	148,238	13,809
JACQUELINE H RICE	Director	Mar 04 '26	Proposed Sale	$10.29	14,406	148,267	0

Adtran Holdings Inc Aktie (ADTN) Neueste Nachrichten

Nov 02, 2026

ABVC BioPharma Announces Closing of Private Placement Offering of Original Issue Discount Senior Convertible Promissory Notes for Gross Proceeds of $3.39 Million - TradingView

Nov 02, 2026

Oct 30, 2026

Vanguard Capital Management reports over 5% passive ownership of ADTRAN (ADTN) as of September 30, 2026. - Stock Titan

Oct 30, 2026

Oct 29, 2026

The board grows from seven to eight as ADTRAN (ADTN) adds an independent director. - Stock Titan

Oct 29, 2026

Oct 19, 2026